Skip to main content

TGA recognises the Gamaleya Institute vaccine (Sputnik V, Russian Federation) for international travel to Australia

The TGA determined that the two dose course of the Gamaleya Institute vaccine (Sputnik V, Russian Federation) would be 'recognised' for the purpose of establishing a traveller's vaccination status.
Published

Related content

Help us improve the Therapeutic Goods Administration site